| 1 |
29135577 | Protease inhibitors and preterm delivery: another piece in the puzzle. | 2018 Jan 14 |
3 |
| 2 |
25831464 | Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1-Infected Patients Starting Efavirenz, Lopinavir-Ritonavir, or Atazanavir-Ritonavir Plus Tenofovir/Emtricitabine: Final 48-Week Results (The Advanz-3 Trial). | 2015 Jun 1 |
1 |
| 3 |
24075526 | Effective treatment of a highly active antiretroviral regimen through jejunostomy. | 2014 Jun |
1 |
| 4 |
24370933 | Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study. | 2014 May |
1 |
| 5 |
24380397 | Immunological function restoration with lopinavir/ritonavir versus efavirenz containing regimens in HIV-infected patients: a randomized clinical trial. | 2014 May |
1 |
| 6 |
23559827 | In-silico designing of a potent analogue against HIV-1 Nef protein and protease by predicting its interaction network with host cell proteins. | 2013 Jan |
1 |
| 7 |
22135137 | Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study. | 2012 Feb |
1 |
| 8 |
21148235 | Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study. | 2011 Feb |
1 |
| 9 |
21732894 | Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine. | 2011 Nov |
3 |
| 10 |
19292590 | Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudine. | 2009 Mar |
2 |
| 11 |
19349850 | Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients. | 2009 Jun 1 |
2 |
| 12 |
18356150 | First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort. | 2008 Jun |
1 |
| 13 |
15983895 | Pilot study of saquinavir and lopinavir/ritonavir twice daily in protease inhibitor-naive HIV-positive patients. | 2005 Mar-Apr |
1 |
| 14 |
16388722 | Different kinetics of immunologic recovery using nelfinavir or lopinavir/ritonavir-based regimens in children with perinatal HIV-1 infection. | 2005 Oct-Dec |
3 |
| 15 |
15222662 | Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir. | 2004 Jun |
1 |
| 16 |
12719666 | [First evaluations of LPV/RTV (Kaletra) efficacy on HIV-positive patients treated with multiple drugs]. | 2003 Mar |
1 |
| 17 |
12458138 | Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors. | 2002 Dec |
1 |